Megestrol acetate for nausea and vomiting from strong chemo
Part of Cancer clinical trials.
This trial tests a medicine called megestrol acetate to see if it can prevent nausea and vomiting caused by very strong chemotherapy for lung cancer. If you are starting a strong chemo treatment, this study may help you feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of lung cancer.
- Your doctor expects you to live at least 3 more months.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and not be breastfeeding.
- You must agree to all study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
This study tests whether a medication called megestrol acetate can help reduce severe tiredness and fatigue in people with advanced breast cancer who are receiving a targeted therapy called T-DXd (trastuzumab deruxtecan). Fatigue is a common side effect that can really impact quality of life.
This study tests a new form of megestrol to prevent nausea and vomiting after your first chemotherapy. It is for people who have never had chemo before and are starting a moderately or highly nauseating treatment.
This study tests whether a special form of megestrol acetate (a medicine used to help with weight and appetite) can improve outcomes when given alongside standard chemotherapy and radiation for people with stage III non-small cell lung cancer. It is for patients who are not overweight and who are not already using other appetite-boosting medications.
This trial tests whether a medicine called megestrol acetate can help improve appetite and weight in people with advanced lung cancer who are malnourished. It's for those who haven't had chemotherapy for their advanced cancer yet.
This trial tests whether a special form of megestrol acetate can help prevent cancer from coming back in people with high-risk head and neck cancer who have had surgery. It is for patients who need additional treatment with radiation or chemoradiation after their operation.
Hear when a new Efficacy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.